| Dr Kristina Marie Manning, MD | |
|
700 Lawrence Expy, Dept. 320, Santa Clara, CA 95051-5173 | |
| (415) 640-9910 | |
| Not Available |
| Full Name | Dr Kristina Marie Manning |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 700 Lawrence Expy, Santa Clara, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053577171 | NPI | - | NPPES |
| 1053577171 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | A107143 (California) | Primary |
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
The Healthcare Businesswomen's Association (HBA) has named sanofi-aventis US as the winner of the 2010 HBA ACE Award for the company's program aimed at building women's leadership across all levels within the company.
Scientists at the University of Massachusetts Medical School have shown that diffuse large B-cell lymphoma (DLBCL) may be susceptible to treatment by re-activating the normal aging program in tumor cells so they can no longer divide.
When treating the diabetes patient, doctors discussed how a "one size fits all" approach to testing is not enough to reveal an individual's risk for cardiovascular disease Saturday at the American Association of Clinical Endocrinologists (AACE) 18th Annual Meeting & Clinical Congress.
The drug lurasidone (trade name Latuda) has been available since November 2014 for the treatment of adults with schizophrenia. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy.
AbbVie, a global biopharmaceutical company, today announced the initiation of six global Phase 3 clinical studies evaluating the safety and efficacy of its all-oral, once-daily, ribavirin-free investigational hepatitis C virus (HCV) regimen, ABT-493, an NS3/4A protease inhibitor, and ABT-530, an NS5A inhibitor, in patients with genotypes 1-6 (GT1-6) chronic HCV infection.
› Verified 5 days ago
| Entity Name | Stanford Health Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437292927 PECOS PAC ID: 6709797491 Enrollment ID: O20031124000348 |
News Archive
The Healthcare Businesswomen's Association (HBA) has named sanofi-aventis US as the winner of the 2010 HBA ACE Award for the company's program aimed at building women's leadership across all levels within the company.
Scientists at the University of Massachusetts Medical School have shown that diffuse large B-cell lymphoma (DLBCL) may be susceptible to treatment by re-activating the normal aging program in tumor cells so they can no longer divide.
When treating the diabetes patient, doctors discussed how a "one size fits all" approach to testing is not enough to reveal an individual's risk for cardiovascular disease Saturday at the American Association of Clinical Endocrinologists (AACE) 18th Annual Meeting & Clinical Congress.
The drug lurasidone (trade name Latuda) has been available since November 2014 for the treatment of adults with schizophrenia. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy.
AbbVie, a global biopharmaceutical company, today announced the initiation of six global Phase 3 clinical studies evaluating the safety and efficacy of its all-oral, once-daily, ribavirin-free investigational hepatitis C virus (HCV) regimen, ABT-493, an NS3/4A protease inhibitor, and ABT-530, an NS5A inhibitor, in patients with genotypes 1-6 (GT1-6) chronic HCV infection.
› Verified 5 days ago
| Entity Name | Lpch Medical Group Div Of Lucile |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417907940 PECOS PAC ID: 0840298543 Enrollment ID: O20061113000232 |
News Archive
The Healthcare Businesswomen's Association (HBA) has named sanofi-aventis US as the winner of the 2010 HBA ACE Award for the company's program aimed at building women's leadership across all levels within the company.
Scientists at the University of Massachusetts Medical School have shown that diffuse large B-cell lymphoma (DLBCL) may be susceptible to treatment by re-activating the normal aging program in tumor cells so they can no longer divide.
When treating the diabetes patient, doctors discussed how a "one size fits all" approach to testing is not enough to reveal an individual's risk for cardiovascular disease Saturday at the American Association of Clinical Endocrinologists (AACE) 18th Annual Meeting & Clinical Congress.
The drug lurasidone (trade name Latuda) has been available since November 2014 for the treatment of adults with schizophrenia. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy.
AbbVie, a global biopharmaceutical company, today announced the initiation of six global Phase 3 clinical studies evaluating the safety and efficacy of its all-oral, once-daily, ribavirin-free investigational hepatitis C virus (HCV) regimen, ABT-493, an NS3/4A protease inhibitor, and ABT-530, an NS5A inhibitor, in patients with genotypes 1-6 (GT1-6) chronic HCV infection.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kristina Marie Manning, MD 700 Lawrence Expy, Dept. 320, Santa Clara, CA 95051-5173 Ph: (415) 640-9910 | Dr Kristina Marie Manning, MD 700 Lawrence Expy, Dept. 320, Santa Clara, CA 95051-5173 Ph: (415) 640-9910 |
News Archive
The Healthcare Businesswomen's Association (HBA) has named sanofi-aventis US as the winner of the 2010 HBA ACE Award for the company's program aimed at building women's leadership across all levels within the company.
Scientists at the University of Massachusetts Medical School have shown that diffuse large B-cell lymphoma (DLBCL) may be susceptible to treatment by re-activating the normal aging program in tumor cells so they can no longer divide.
When treating the diabetes patient, doctors discussed how a "one size fits all" approach to testing is not enough to reveal an individual's risk for cardiovascular disease Saturday at the American Association of Clinical Endocrinologists (AACE) 18th Annual Meeting & Clinical Congress.
The drug lurasidone (trade name Latuda) has been available since November 2014 for the treatment of adults with schizophrenia. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy.
AbbVie, a global biopharmaceutical company, today announced the initiation of six global Phase 3 clinical studies evaluating the safety and efficacy of its all-oral, once-daily, ribavirin-free investigational hepatitis C virus (HCV) regimen, ABT-493, an NS3/4A protease inhibitor, and ABT-530, an NS5A inhibitor, in patients with genotypes 1-6 (GT1-6) chronic HCV infection.
› Verified 5 days ago
David Tran La, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 710 Lawrence Expy, Santa Clara, CA 95051 Phone: 408-554-9810 | |
Lynne Chang Wu, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2652 El Camino Real, Santa Clara, CA 95051 Phone: 408-524-5952 | |
Karen Chan, Pediatrics Medicare: Medicare Enrolled Practice Location: 710 Lawrence Expy, Santa Clara, CA 95051 Phone: 408-851-1000 | |
Emma Steinberg, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 700 Lawrence Expy, Santa Clara, CA 95051 Phone: 408-851-1000 | |
Rebecca L. Redman, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 710 Lawrence Expy, Santa Clara, CA 95051 Phone: 408-851-1000 | |
Yu-tzu Tseng, M.D Pediatrics Medicare: Medicare Enrolled Practice Location: 710 Lawrence Expy, Santa Clara, CA 95051 Phone: 408-554-9810 |